More Severe Manifestations and Poorer Short-Term Prognosis of Ganglioside-Associated Guillain-Barré Syndrome in Northeast China

Ganglioside as a neurotrophic drug has been hitherto widely used in China, although Guillain-Barré syndrome (GBS) following intravenous ganglioside treatment was reported in Europe several decades ago. We identified 7 patients who developed GBS after intravenous use of gangliosides (ganglioside+ gro...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Xiujuan, Wu, Wei, Wang, Zhengzheng, Shen, Donghui, Pan, Wei, Wang, Ying, Wu, Limin, Wu, Xiaokun, Feng, Jiachun, Liu, Kangding, Zhu, Jie, Zhang, Hong-Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4118971/
https://www.ncbi.nlm.nih.gov/pubmed/25084153
http://dx.doi.org/10.1371/journal.pone.0104074

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4118971/
https://www.ncbi.nlm.nih.gov/pubmed/25084153
http://dx.doi.org/10.1371/journal.pone.0104074

Ejemplares similares